Table 5.
Antimicrobial resistance profile of diarrheagenic E. coli isolated from stool samples collected from children
| DEC (n) | AMP | AK | C | CN | CI | CF | COT | CST | MRP | NX | G | CFM | DO | OF | MDR (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| a-EPEC (29) | 21 (72.4) | 06 (20.7) | 14 (48.3) | 14 (48.3) | 22 (75.9) | 10 (34.5) | 09 (31.0) | 24 (82.8) | 06 (20.7) | 12 (41.4) | 04 (13.8) | 21 (72.4) | 12 (41.4) | 14 (48.3) | 14 (48.3) |
| t-EPEC (21) | 14 (66.7) | 08 (38.1) | 05 (23.8) | 12 (57.1) | 12 (57.1) | 03 (14.3) | 08 (38.1) | 16 (76.2) | 06 (28.6) | 09 (42.6) | 07 (33.3) | 12 (57.1) | 12 (57.1) | 07 (33.3) | 07 (24.1) |
| EIEC (08) | 07 (87.5) | 01 (12.5) | 00 (0) | 06 (75) | 07 (87.5) | 04 (50) | 07 (87.5) | 04 (50) | 05 (62.5) | 01 (12.5) | 05 (62.5) | 05 (62.5) | 05 (62.5) | 05 (62.5) | 03 (37.5) |
| Total (58) | 42 (72.4) | 15 (25.9) | 19 (32.8) | 32 (55.2) | 41 (70.7) | 17 (29.3) | 24 (41.4) | 44 (75.9) | 17 (29.3) | 22 (37.9) | 16 (27.6) | 38 (65.5) | 29 (50) | 26 (44.8) | 24 (41.4) |
Figures in parenthesis denotes the % of the samples
MDR multi drug resistant, a-EPEC atypical enteropathogenic Escherichia coli, t-EPEC typical enteropathogenic Escherichia coli, EIEC enteroinvasive Escherichia coli, μg microgram, Antibiotics ampicillin (AMP10 = 10 μg), amikacin (AK10 = 10 μg), chloramphenicol (C 30 = 30 μg), ceftriaxone (CI 10 = 10 μg), cephalexin (CN30 = 30 μg), ciprofloxacin (CF10 = 10 μg), co-trimoxazole (COT25 = trimethoprim 1.25 μg and sulphamethoxazole 23.75 μg), cefoperazone–tazobactam (CST 75–10 μg), meropenem (MRP10 = 10 μg), norfloxacin (NX10 = 10 μg), gentamicin (G10 = 10 μg), cefixime (CFM 5 = 5 μg), doxycycline hydrochloride (DO10 = 10 μg) and ofloxacin (OF 5 = 5 μg)